Interview: Dr. Varun Sethi – VP Healthcare, DKSH Singapore &…
DKSH’s VP of Healthcare in Singapore and Malaysia, Dr. Varun Sethi deconstructs the essence of what it means to be a Market Expansion Services provider, while highlighting aspects of the…
As the leading Market Expansion Services Group with a focus on Asia, DKSH helps companies to grow their business in new or existing markets. We are a Swiss company headquartered in Zurich with 150 years of uninterrupted business presence in Asia.
We are one of the top 30 Swiss companies ranked by sales and employees with 770 business locations in 36 countries — 740 of them in Asia — and 28,300 specialized staff.
We provide our partners with sound expertise and on-the- ground logistics, based on a comprehensive network of unique size and depth. Our business activities are organized into four highly specialized Business Units that mirror our fields of expertise: Consumer Goods, Healthcare, Performance Materials and Technology.
With a strong Swiss heritage, DKSH has a long tradition of doing business in and with Asia and is deeply rooted in communities and businesses across Asia Pacific.
Contact
24 Penjuru Rd, No. 03-02
609128 Singapore
+65 6471 1466
DKSH’s VP of Healthcare in Singapore and Malaysia, Dr. Varun Sethi deconstructs the essence of what it means to be a Market Expansion Services provider, while highlighting aspects of the…
UPS APAC’s Bee Lim describes how the logistics giant responded to the unprecedented challenges thrown up by the COVID-19 pandemic, the trends that the pandemic has accelerated in the region,…
Cerecin’s Charles Stacey outlines the company’s progress in expanding its lead asset into migraine and infantile spasms, how its funding strategy has evolved, why Singapore is still a logical base,…
Clarence Ngui describes how global orthopaedic product giant Zimmer Biomet has pivoted in APAC in response to the COVID-19 pandemic; how medical education needs differ across the vast APAC region;…
Asia-Pacific, as home to 50 percent of the world’s new cancer cases each year and with deaths caused by cancer expected to increase by 36 percent by 2030, has a…
J&J Singapore’s Guillermo Frydman outlines how his affiliate negotiated the COVID-19 pandemic; why managing J&J’s pharma, medical devices, vision care and consumer businesses together offers unique opportunities to engage as…
COVID-19 has pushed diagnostics to the forefront of healthcare conversations across the world. Here, three leading lights from the Asia-Pacific medtech industry weigh in on what the new diagnostics paradigm…
Lucas Chan, Scientific Founder and CSO of CellVec, a Singapore-based CDMO that specializes in the development and manufacture of viral vectors for clinical gene therapy, discusses how his company is…
Shiva Kannan, VP and Chief Information Officer for GE Healthcare in over 120 countries, discusses the company’s journey over the past few years and the company-wide digital transformation he has…
Regulatory harmonisation for medical devices between countries in Asia-Pacific has long been a challenging issue, predominantly due to the extreme variation in cultures, economic development, governmental models, and healthcare systems…
Mervyn Lim, Vice President, ResMed Asia, shares the company’s journey through COVID-19 in the region, how the company is building on their digitalisation experience, his view on how different stakeholders…
Leonora Lim, DHL’s Asia-Pacific VP for Life Sciences and Healthcare, Customer Solutions & Innovation, dives into the industry’s challenges during the pandemic, the continuing importance of Singapore as a regional…
Siemens Healthineers Singapore’s Ai Li Siow outlines how her affiliate has pivoted in order to continue to support its customers in what was an “unprecedented 2020.” She also explains how…
See our Cookie Privacy Policy Here
